- Home
- DAVE vs OPK Comparison
DAVE vs OPK Comparison
Compare DAVE & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAVE
- OPK
- Stock Information
- Founded
- DAVE 2017
- OPK 2007
- Country
- DAVE United States
- OPK United States
- Employees
- DAVE N/A
- OPK N/A
- Industry
- DAVE Retail: Computer Software & Peripheral Equipment
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- DAVE Technology
- OPK Health Care
- Exchange
- DAVE Nasdaq
- OPK Nasdaq
- Market Cap
- DAVE 1.2B
- OPK 1.0B
- IPO Year
- DAVE N/A
- OPK 1995
- Fundamental
- Price
- DAVE $98.80
- OPK $1.58
- Analyst Decision
- DAVE Strong Buy
- OPK Strong Buy
- Analyst Count
- DAVE 7
- OPK 3
- Target Price
- DAVE $99.86
- OPK $2.75
- AVG Volume (30 Days)
- DAVE 353.8K
- OPK 2.9M
- Earning Date
- DAVE 03-04-2025
- OPK 02-25-2025
- Dividend Yield
- DAVE N/A
- OPK N/A
- EPS Growth
- DAVE N/A
- OPK N/A
- EPS
- DAVE 3.12
- OPK N/A
- Revenue
- DAVE $319,355,000.00
- OPK $711,408,000.00
- Revenue This Year
- DAVE $34.76
- OPK N/A
- Revenue Next Year
- DAVE $19.55
- OPK $0.00
- P/E Ratio
- DAVE $31.68
- OPK N/A
- Revenue Growth
- DAVE 30.00
- OPK N/A
- 52 Week Low
- DAVE $18.50
- OPK $0.86
- 52 Week High
- DAVE $108.50
- OPK $1.76
- Technical
- Relative Strength Index (RSI)
- DAVE 59.27
- OPK 55.91
- Support Level
- DAVE $86.63
- OPK $1.47
- Resistance Level
- DAVE $103.30
- OPK $1.51
- Average True Range (ATR)
- DAVE 6.29
- OPK 0.04
- MACD
- DAVE 0.50
- OPK 0.01
- Stochastic Oscillator
- DAVE 79.03
- OPK 94.44
About DAVE Dave Inc.
Dave Inc is a financial services company. It is engaged in offering banking app that offers its customers banking, financial insights, overdraft protection, building credit, and finding side gigs.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.